Health Information from Dr. Lester

Caution on new anti-obesity drug in kids

Anti-obesity drugs that work by blocking brain molecules similar to those in marijuana could also interfere with neural development in young children, as per a new study from MITs Picower Institute for Learning and Memory.

Marijuana is known to be an appetite stimulant, and a new class of anti-obesity drugssuch as rimonabant (trade name Acomplia) developed by Sanofi-Aventis and awaiting approval for use in the United Stateswork by blocking brain receptors that bind to marijuana and other cannabinoids.

Marijuana, derived from the plant Cannabis sativa, contains special active compounds that are referred to collectively as cannabinoids. But other cannabinoids (endocannabinoids) are generated naturally inside the body.

The MIT study, which was done in mice, observed that blocking cannabinoid receptors could also suppress the adaptive rewiring of the brain necessary for neural development in children. The work is published in the May 8 issue of Neuron.

Our finding of a profound disruption of cortical plasticity in juvenile mice suggests caution is advised in the use of such compounds in children, wrote lead author Mark F. Bear, director of the Picower Institute and Picower Professor of Neuroscience.

The scientists investigated plasticitythe brains ability to change in response to experienceby temporarily depriving newborn mice of vision in one eye soon after birth. This well-known experiment induces a long-lasting loss of synapses that causes blindness in the covered eye, while synapses shift to the uncovered eye. How and where this synaptic shift occurs in the primary visual cortex has remained controversial.

Understanding the mechanism behind this phenomenon is key because the same brain mechanisms are used for normal development and may go awry in conditions that cause developmental delays in humans, and may reappear in old age and contribute to synaptic loss during Alzheimer’s disease, Bear said.

In mice, the MIT scientists found, even one day of deprivation from one eye starts the shift to dominance of the uncovered eye. But injecting the mice with a cannabinoid receptor blocker halted the shift in certain brain regions, indicating that cannabinoids play a key role in early synaptic development.

Blocking cannabinoids receptors could thwart this developmental process, the scientists said. Source

Click Here For More Information

Click Here To Enter The Weight Loss Site

obesity Anti Obesity Alzheimer’s Disease

Subscribe

More »

Source: Anti Obesity Alzheimer’s Disease

Add comment May 30th, 2008

Newspaper Site with Health Information

If you’re looking for health information, you might find useful TheGoodLifeOfGeorgia.com. This is the website of a print publication that often carries health tips.

Add comment May 29th, 2008

Potato king J.R. Simplot, U.S. fry innovator, dies - Reuters

Potato king J.R. Simplot, U.S. fry innovator, dies - Reuters
BOISE, Idaho (Reuters) - J.R. Simplot, the billionaire founder of the Boise, Idaho-based agriculture business that bears his name and who helped make French fries a staple of the American diet and waistline, died on Sunday at the age of 99, officials
Source: www.reuters.com

Slice of life - Hindustan Times
When Advertising professional Nayantara Mehra joined a gym to lose some weight, the dietician there handed her a diet plan that Mehra looked at and gagged. No, she wasn’t against increasing her intake of fruits and vegetables and soups and all the
Source: www.hindustantimes.com

Make My Day - American Reporter
INDIANAPOLIS, Ind. — We are food-obsessed in this country - how it’s made, where it comes from, whether it’s organic, and how much we eat - or, more importantly, what we don’t eat. Barry Glassner, author of the book “The Gospel of Food,” says that
Source: www.american-reporter.com

Add comment May 27th, 2008